Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years.
Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all.
AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
Eyeglass World®, a leading retailer of affordable prescription eyewear, is the first national chain to launch a retail collection of prescription lenses for smart glass technologies in the U.S. The debut of specially designed prescription lens options for wearable brands including Glass, Recon, Vuzix and Epson coincides with Eyeglass World’s retail expansion into California. On Friday, the company celebrated the grand opening of a Vista, California location – the first of eight Eyeglass World stores planned for the San Diego area by June 2016.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7544551-eyeglass-world-expands-debuts-smart-glass/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Turning your clocks ahead an hour on March 8 for the start of Daylight Savings Time may be known as the unofficial start to spring, but for many, it’s known as the day we lose an hour of sleep. As you prepare to change your clocks on Sunday, take that opportunity to evaluate your sleeping habits. The loss of that hour of sleep can turn minor sleep issues into major ones.
“When we move our clock forward or backward, our internal clock becomes out of sync with the external time,” says Dr. Daniel Shade, Board Certified Sleep Specialist and Director of the AHN Sleep Disorders Center. “The best way to combat this is to expose ourselves to light and let our bodies resynchronize.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7447951-remworks-daylight-savings-sleep-coach/
A recent survey conducted by Harris Poll on behalf of the newly-formed Coalition to Prevent Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Misuse (CPAMM) finds that college students’ perceptions and attitudes towards the misuse, abuse and diversion of ADHD prescription stimulants are complex. The findings paint a portrait of students who recognize the risks of misuse, but understand why some students may choose to misuse, given the academic pressures in today’s college environment. CPAMM intends to use the findings to inform and develop educational campaigns to help prevent nonmedical use of ADHD prescription stimulants. The survey was conducted online between May 15 and June 11, 2014 among 2,056 US college students (full-time, 91%, part-time, 9%), defined as adults aged 18 to 24 enrolled and seeking a degree at a 4-year college or university and attending at least some in-person classes.1
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7373051-cpamm-survey-reveals-college-students-adhd-prescription-stimulant-abuse-misuse-and-diversion/
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
Otsuka Pharmaceutical Co., Ltd. launched a newly designed English corporate website that was collaborated with an Amsterdam-based creative agency to reflect our philosophy: “Otsuka-people creating new products for better health worldwide”. With additional new content designed creatively, the new website adopts an innovative, personal design to attract people from around the world.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62657-otsuka-pharmaceutical-new-global-website
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
With the Dec. 7 deadline for Medicare’s annual enrollment period fast approaching, Smart Insurance Company is working with Walgreens to offer in–store consultations with licensed SmartD Rx plan agents, available at select Walgreens to speak with Medicare beneficiaries who are either enrolling in a new Part D prescription drug plan or evaluating their current coverage options.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59273-smart-insurance-company-walgreens-smartd-rx-open-enrollment-ends-dec-7
Golf Lessons Irvine http://www.GolfSwingPrescription.com Call (949) 554-9926 - Are you looking for golf lessons in Irvine (or the nearby area) or just golfing tips in general? Ryan Trengrove (Class A PGA member), owner of a state-of-the-art indoor golf training facility called Golf Swing Prescription (Laguna Hills, CA), shows you how conquer one of the most common problems in Golf - keeping your lower body stable while swinging the golf club!
Ryan states that if you can get your lower body to be more stable, you will have a lot more fun when you are playing golf. Ryan shows you a video of one of Golf’s great player’s, Davis Love III, to display great lower body stability. Ryan points out how Davis’s lower body not only stays in the “same sit” and “same flex” as Davis goes up to the top of his golf swing, but, also when he goes back down to hit the golf ball.
Ryan also points out the importance of NOT having your lower body “sway”, but to have it “swivel” instead. The goal is to keep the lower body in its flex, so that you can have it sit, and keep the hip in the same spot. If you are able to do this, as you come from the top of your swing down to the ball, you should make solid contact.
In order to assist you in achieving better lower body stability, Ryan shows you a golf drill called the “Feet Together Drill”. This drill has the golfer setup to hit the golf ball with their feet together, which will prevent the golfer from going “side to side” during the swing. The idea behind the drill is to have the golfer hit a number of shots with their feet together so that they can get the “feeling” of not “going side to side” and being stable. Once you get use to the feeling, then you can widen your golf stance, trying to maintain the same “stable feeling” felt during the drill, with your base “swiveling” and not “swaying”.
Ryan goes on to show you one more drill to help you that he got from Golf Professional, Nick Faldo called the “Right Foot Forward – Left Leg Back Drill” (just switch if you are left handed). The goal of this drill is to help you focus on keeping the flex in your right knee. You get in your normal golf stance, but, just move your left leg back a couple of feet, and then hit the ball. So what this drill does is to focus you on keeping the proper flex in your right knee.
What Ryan wants you to do is to work on the combination of the “Feet Together Drill” and the “Right Foot Forward –Left Leg Back Drill” so that when you get up to your golf ball you focus on staying centered – no “side to side” and keeping your right knee flexed. Ryan points out that if you can do this, that you should make better contact with the ball!
Ryan performs over 1,500 golf lessons per year, when compared to the average club pro that only conducts approximately 300. Ryan is extremely popular for a reason; his indoor
